Ketamine-Induced Mood Disorder

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Ketamine-Induced Mood Disorder trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingPhase 2

NCT02122562

Ketamine Alcohol (in Treatment-Resistant Depression)

A single subanesthetic dose infusion of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine has rapid and robust antidepressant effects in patients wit…

United States60 participantsStarted 2014-04-23

Treatment: Ketamine

All recent trials (13 shown)

CompletedNot Applicable

NCT06133309

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Ketamine is an anaesthetic used in low doses to treat depressive disorders. A related molecule, Esketamine, has recently been launched on the market for the tre…

France15 participantsStarted 2024-03-19

Treatment: Experiential Phenomenological Interview

Not Yet RecruitingPhase 1/2

NCT07247370

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

To assess the safety, feasibility and preliminary efficacy of ketamine-enhanced therapy (KET) for alcohol use disorder (AUD) and comorbid major depressive disor…

Australia20 participantsStarted 2025-12-10

Treatment: Ketamine, Cognitive Behavioural Therapy

Ketamine-Induced Mood Disorder

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Ketamine Alcohol (in Treatment-Resistant Depression)

All recent trials (13 shown)

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Ketamine Alcohol (in Treatment-Resistant Depression)

All recent trials (13 shown)

Phenomenological Explorations of the Esketamine-Induced Transient Dissociative State

Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)

Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

KAP for Depression in Abstinent Opioid Users

Ketamine for OUD and Comorbid Depression (OUDCD)

In Vitro Modeling of Drug-resistant Psychiatric Disorders Using Induced Pluripotent Cells

The Role of Ketamine and Dexmedetomidine in Opioid-Sparing Analgesia

Ketamine IV Classic Protocol : Five Years Follow up

Naltrexone Plus Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder

Effects of Low Dose Ketamine Given at Induction of Anesthesia on Postoperative Mood in Patients With Depressive Symptoms

A Study to Investigate Evoked Potentials as Markers of Ketamine-induced Cortical Plasticity in Patients With Major Depre…

The Effect of Minocycline on Relapse After Successful Intravenous Ketamine/Minocycline-induced Symptoms Response in Subj…